tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

IMPL

Impel Pharmaceuticals files for Chapter 11 to facilitate sale
The FlyImpel Pharmaceuticals files for Chapter 11 to facilitate sale
4M ago
IMPL
IMPL Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
IMPL Upcoming Earnings Report: What to Expect?
6M ago
IMPL
Impel Pharmaceuticals announces exploration of strategic alternatives
PremiumThe Fly
Impel Pharmaceuticals announces exploration of strategic alternatives
7M ago
IMPL
Impel Pharmaceuticals downgraded to Hold from Buy at JonesResearch
PremiumThe Fly
Impel Pharmaceuticals downgraded to Hold from Buy at JonesResearch
8M ago
IMPL
Impel Pharma (NASDAQ:IMPL) Plummets on Viability Concerns
PremiumMarket News
Impel Pharma (NASDAQ:IMPL) Plummets on Viability Concerns
8M ago
IMPL
Impel in forbearance discussions with Oaktree Fund Administration
PremiumThe FlyImpel in forbearance discussions with Oaktree Fund Administration
8M ago
IMPL
Is IMPL a Buy, Before Earnings?
PremiumPre-Earnings
Is IMPL a Buy, Before Earnings?
9M ago
IMPL
Impel Pharmaceuticals to preset real-world data for Trudhesa
PremiumThe Fly
Impel Pharmaceuticals to preset real-world data for Trudhesa
10M ago
IMPL
Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society
PremiumPress Releases
Impel Pharmaceuticals to Present New Real-World Data for Trudhesa® at the 65th Annual Scientific Meeting of the American Headache Society
10M ago
IMPL
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
PremiumPress Releases
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
12M ago
IMPL
Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023
PremiumPress Releases
Impel Pharmaceuticals to Report First Quarter 2023 Financial Results on Friday, May 12, 2023
12M ago
IMPL
Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine Medications
PremiumPress Releases
Impel Pharmaceuticals Presents New Data at AAN 2023 Suggesting Trudhesa® Nasal Spray is Safe to Use When Co-Administered With Commonly Prescribed Migraine Medications
12M ago
IMPL
Impel Pharmaceuticals presents new data on Trudhesa
PremiumThe FlyImpel Pharmaceuticals presents new data on Trudhesa
12M ago
IMPL
Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors
PremiumPress Releases
Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors
1y ago
IMPL
Impel Pharmaceuticals sees Trudhesa delivering 80K-110K TRx for 2023
PremiumThe Fly
Impel Pharmaceuticals sees Trudhesa delivering 80K-110K TRx for 2023
1y ago
IMPL
Impel Pharmaceuticals expects cash to fund operations into 3Q23
PremiumThe Fly
Impel Pharmaceuticals expects cash to fund operations into 3Q23
1y ago
IMPL
Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
PremiumPress Releases
Impel Pharmaceuticals Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
1y ago
IMPL
Impel Pharmaceuticals reports Q4 adjusted EPS (97c), consesnus ($1.11)
PremiumThe Fly
Impel Pharmaceuticals reports Q4 adjusted EPS (97c), consesnus ($1.11)
1y ago
IMPL
Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023
PremiumPress Releases
Impel Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Friday, March 24, 2023
1y ago
IMPL
Impel Pharmaceuticals to Participate in Upcoming Investor Conferences in March
PremiumPress ReleasesImpel Pharmaceuticals to Participate in Upcoming Investor Conferences in March
1y ago
IMPL
Impel Pharmaceuticals announces strategic reprioritization, departure of CMO
PremiumThe Fly
Impel Pharmaceuticals announces strategic reprioritization, departure of CMO
1y ago
IMPL
Impel Pharmaceuticals Announces Strategic Repriortization, Continues Focus on Maximizing Trudhesa® Commercial Opportunity
PremiumPress Releases
Impel Pharmaceuticals Announces Strategic Repriortization, Continues Focus on Maximizing Trudhesa® Commercial Opportunity
1y ago
IMPL

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >